RSS-Feed abonnieren
DOI: 10.1055/s-0033-1348464
Donor Selection and Management
Publikationsverlauf
Publikationsdatum:
02. Juli 2013 (online)
![](https://www.thieme-connect.de/media/srccm/201303/lookinside/thumbnails/10.1055-s-0033-1348464-1.jpg)
Abstract
This article reviews recent developments in the selection, assessment, and management of the potential lung donor, which aim to increase donor organ use. The scarcity of suitable donor organs continues to limit lung transplantation, but the situation is changing. An expanded donor pool, including the now widespread use of donation after cardiac death (DCD) lungs; the use of extended donor lungs; and the ability of ex vivo lung perfusion (EVLP) to evaluate and improve donor lungs are key initiatives. These strategies have substantially lifted donor lung utilization rates from historically low levels of less than 15% to rates greater than 50%. Indeed, since 2004 there has been an accelerated year-on-year increase in the number of lungs transplanted globally. Intermediate-term studies are now confirming that long-term outcomes are not being significantly compromised and that more individuals with terminal, symptomatic lung disease are being transplanted. It is now quite clear that many of the historical factors used to define a lung as “extended” do not actually produce significantly inferior outcomes. There has been a dramatic increase in research and clinical interest in donor lung assessment, management, and novel therapeutic strategies. The lessons learned are now being applied widely beyond the lung as researchers aim to increase availability and optimize other solid organs for transplantation.
-
References
- 1 Christie JD, Edwards LB, Kucheryavaya AY , et al; International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report—2012. J Heart Lung Transplant 2012; 31 (10) 1073-1086
- 2 Levvey BJ, Harkess M, Hopkins P , et al. Excellent clinical outcomes from a national donation-after-determination-of-cardiac-death lung transplant collaborative. Am J Transplant 2012; 12 (9) 2406-2413
- 3 Stehlik J, Edwards LB, Kucheryavaya AY , et al; International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report—2012. J Heart Lung Transplant 2012; 31 (10) 1052-1064
- 4 Mason DP, Brown CR, Murthy SC , et al. Growing single-center experience with lung transplantation using donation after cardiac death. Ann Thorac Surg 2012; 94 (2) 406-411 , discussion 411–412
- 5 Botha P, Trivedi D, Weir CJ , et al. Extended donor criteria in lung transplantation: impact on organ allocation. J Thorac Cardiovasc Surg 2006; 131 (5) 1154-1160
- 6 Snell GI, Griffiths A, Levvey BJ, Oto T. Availability of lungs for transplantation: exploring the real potential of the donor pool. J Heart Lung Transplant 2008; 27 (6) 662-667
- 7 Snell GI, Westall GP. Selection and management of the lung donor. Clin Chest Med 2011; 32 (2) 223-232
- 8 Cypel M, Yeung JC, Liu M , et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011; 364 (15) 1431-1440
- 9 Ingemansson R, Eyjolfsson A, Mared L , et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg 2009; 87 (1) 255-260
- 10 Detry O, Le Dinh H, Noterdaeme T , et al. Categories of donation after cardiocirculatory death. Transplant Proc 2012; 44 (5) 1189-1195
- 11 Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc 1995; 27 (5) 2893-2894
- 12 Egan TM. Non-heart-beating donors in thoracic transplantation. J Heart Lung Transplant 2004; 23 (1) 3-10
- 13 Steen S, Sjöberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet 2001; 357 (9259) 825-829
- 14 Gomez-de-Antonio D, Campo-Cañaveral JL, Crowley S , et al. Clinical lung transplantation from uncontrolled non-heart-beating donors revisited. J Heart Lung Transplant 2012; 31 (4) 349-353
- 15 Mason DP, Rajeswaran J, Li L , et al. Effect of changes in postoperative spirometry on survival after lung transplantation. J Thorac Cardiovasc Surg 2012; 144 (1) 197-203
- 16 Van De Wauwer C, Verschuuren EA, van der Bij W, Nossent GD, Erasmus ME. The use of non-heart-beating lung donors category III can increase the donor pool. Eur J Cardiothorac Surg 2011; 39 (6) e175-e180 , discussion e180
- 17 Zych B, Popov AF, Amrani M , et al. Lungs from donation after circulatory death donors: an alternative source to brain-dead donors? Midterm results at a single institution. Eur J Cardiothorac Surg 2012; 42 (3) 542-549
- 18 Levvey B. Excellent early results of Australian DCD lung transplantation. J Heart Lung Transplant 2010; 31 (2) S63-S64
- 19 Kang CH, Anraku M, Cypel M , et al. Transcriptional signatures in donor lungs from donation after cardiac death vs after brain death: a functional pathway analysis. J Heart Lung Transplant 2011; 30 (3) 289-298
- 20 Stamenkovic S, Van Raemdonck D, Verleden G , et al. Bilateral lobar lung transplantation—the first two cases in Belgium. Acta Chir Belg 2007; 107 (2) 201-204
- 21 Keating DT, Westall GP, Marasco SF , et al. Paediatric lobar lung transplantation: addressing the paucity of donor organs. Med J Aust 2008; 189 (3) 173-175
- 22 Sweet SC, Wong HH, Webber SA , et al. Pediatric transplantation in the United States, 1995-2004. Am J Transplant 2006; 6 (5, Pt 2) 1132-1152
- 23 Tydén G, Kumlien G, Genberg H, Sandberg J, Lundgren T, Fehrman I. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005; 5 (1) 145-148
- 24 Nelson PW, Bryan CF. When will real benefits for minority patients be realized with A2—>B transplants?. Transplantation 2010; 89 (11) 1310-1311
- 25 Banner NR, Rose ML, Cummins D , et al. Management of an ABO-incompatible lung transplant. Am J Transplant 2004; 4 (7) 1192-1196
- 26 Pierson III RN, Loyd JE, Goodwin A , et al. Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy. Transplantation 2002; 74 (1) 79-84
- 27 Strüber M, Warnecke G, Hafer C , et al. Intentional ABO-incompatible lung transplantation. Am J Transplant 2008; 8 (11) 2476-2478
- 28 Grasemann H, de Perrot M, Bendiak GN , et al. ABO-incompatible lung transplantation in an infant. Am J Transplant 2012; 12 (3) 779-781
- 29 Strüber M, Warnecke G, Hafer C , et al. Intentional ABO-incompatible lung transplantation. Am J Transplant 2008; 8 (11) 2476-2478
- 30 Patel M, Carby M, Rice A, Cummins D, Banner NR. Medium-term outcome of an ABO incompatible lung transplant. Am J Transplant 2010; 10 (3) 702-703
- 31 Barnett AN, Hudson A, Hadjianastassiou VG , et al. Distribution of ABO blood group antibody titers in pediatric patients awaiting renal transplantation: implications for organ allocation policy. Transplantation 2012; 94 (4) 362-368
- 32 Kobayashi T, Liu D, Ogawa H , et al. Removal of blood group A/B antigen in organs by ex vivo and in vivo administration of endo-beta-galactosidase (ABase) for ABO-incompatible transplantation. Transpl Immunol 2009; 20 (3) 132-138
- 33 Yamane M, Sano Y, Toyooka S, Okazaki M, Date H, Oto T. Living-donor lobar lung transplantation for pulmonary complications after hematopoietic stem cell transplantation. Transplantation 2008; 86 (12) 1767-1770
- 34 Bando T, Date H, Minami M , et al. First registry report: lung transplantation in Japan: The Japanese Society of Lung and Heart-Lung Transplantation. Gen Thorac Cardiovasc Surg 2008; 56 (1) 17-21
- 35 Sundaresan S, Trachiotis GD, Aoe M, Patterson GA, Cooper JD. Donor lung procurement: assessment and operative technique. Ann Thorac Surg 1993; 56 (6) 1409-1413
- 36 Orens JB, Boehler A, de Perrot M , et al; Pulmonary Council, International Society for Heart and Lung Transplantation. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant 2003; 22 (11) 1183-1200
- 37 Botha P, Rostron AJ, Fisher AJ, Dark JH. Current strategies in donor selection and management. Semin Thorac Cardiovasc Surg 2008; 20 (2) 143-151
- 38 Van Raemdonck D, Neyrinck A, Verleden GM , et al. Lung donor selection and management. Proc Am Thorac Soc 2009; 6 (1) 28-38
- 39 Snell GI, Westall GP. Donor selection and management. Curr Opin Organ Transplant 2009; 14 (5) 471-476
- 40 Pierre AF, Sekine Y, Hutcheon MA, Waddell TK, Keshavjee SH. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg 2002; 123 (3) 421-427 , discussion, 427–428
- 41 Schiavon M, Falcoz PE, Santelmo N, Massard G. Does the use of extended criteria donors influence early and long-term results of lung transplantation?. Interact Cardiovasc Thorac Surg 2012; 14 (2) 183-187
- 42 Meers C, Van Raemdonck D, Verleden GM , et al. The number of lung transplants can be safely doubled using extended criteria donors; a single-center review. Transpl Int 2010; 23 (6) 628-635
- 43 Levvey B. The Lung Allocation Score in a non-US lung transplant program. J Heart Lung Transplant 2009; 29 (2) S135
- 44 Gabbay E, Williams TJ, Griffiths AP , et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 1999; 160 (1) 265-271
- 45 Snell GI, Griffiths A, Macfarlane L , et al. Maximizing thoracic organ transplant opportunities: the importance of efficient coordination. J Heart Lung Transplant 2000; 19 (4) 401-407
- 46 Oto T, Levvey BJ, Whitford H , et al. Feasibility and utility of a lung donor score: correlation with early post-transplant outcomes. Ann Thorac Surg 2007; 83 (1) 257-263
- 47 Iribarne A, Russo MJ, Davies RR , et al. Despite decreased wait-list times for lung transplantation, lung allocation scores continue to increase. Chest 2009; 135 (4) 923-928
- 48 Porro GA, Valenza F, Coppola S , et al. Use of the Oto lung donor score to analyze the 2010 donor pool of the Nord Italia Transplant program. Transplant Proc 2012; 44 (7) 1830-1834
- 49 Reyes KG, Mason DP, Thuita L , et al. Guidelines for donor lung selection: time for revision?. Ann Thorac Surg 2010; 89 (6) 1756-1764 , discussion 1764–1765
- 50 Organ Procurement and Transplant Network; 2006 Annual Report. http://www.optn.org/AR2006
- 51 Zafar F, Khan MS, Heinle JS , et al. Does donor arterial partial pressure of oxygen affect outcomes after lung transplantation? A review of more than 12,000 lung transplants. J Thorac Cardiovasc Surg 2012; 143 (4) 919-925
- 52 Government of Australia. Deaths in Australia. Canberra, Australia: Australian Bureau of Statistics; 2008: 73
- 53 Opdam HI, Silvester W. Potential for organ donation in Victoria: an audit of hospital deaths. Med J Aust 2006; 185 (5) 250-254
- 54 Ojo AO, Wolfe RA, Leichtman AB, Dickinson DM, Port FK, Young EW. A practical approach to evaluate the potential donor pool and trends in cadaveric kidney donation. Transplantation 1999; 67 (4) 548-556
- 55 Meyers BF, Patterson GA. Current status of lung transplantation. Adv Surg 2000; 34: 301-318
- 56 De Perrot M, Waddell TK, Shargall Y , et al. Impact of donors aged 60 years or more on outcome after lung transplantation: results of an 11-year single-center experience. J Thorac Cardiovasc Surg 2007; 133 (2) 525-531
- 57 Penn I, Halgrimson CG, Starzl TE. De novo malignant tumors in organ transplant recipients. Transplant Proc 1971; 3 (1) 773-778
- 58 Chen F, Karolak W, Cypel M, Keshavjee S, Pierre A. Intermediate-term outcome in lung transplantation from a donor with glioblastoma multiforme. J Heart Lung Transplant 2009; 28 (10) 1116-1118
- 59 Armanios MY, Grossman SA, Yang SC , et al. Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literature. Neuro-oncol 2004; 6 (3) 259-263
- 60 Chen H, Shah AS, Girgis RE, Grossman SA. Transmission of glioblastoma multiforme after bilateral lung transplantation. J Clin Oncol 2008; 26 (19) 3284-3285
- 61 Penn I. Donor transmitted disease: cancer. Transplant Proc 1991; 23 (5) 2629-2631
- 62 Bajaj NS, Watt C, Hadjiliadis D , et al. Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection. Transpl Int 2010; 23 (7) e26-e31
- 63 Gandhi MJ, Strong DM. Donor derived malignancy following transplantation: a review. Cell Tissue Bank 2007; 8 (4) 267-286
- 64 Kauffman HM, Cherikh WS, McBride MA, Cheng Y, Hanto DW. Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update. Transplantation 2007; 84 (2) 272-274
- 65 Bonde PN, Patel ND, Borja MC , et al. Impact of donor lung organisms on post-lung transplant pneumonia. J Heart Lung Transplant 2006; 25 (1) 99-105
- 66 Avlonitis VS, Krause A, Luzzi L , et al. Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation. Eur J Cardiothorac Surg 2003; 24 (4) 601-607
- 67 Mattner F, Kola A, Fischer S , et al. Impact of bacterial and fungal donor organ contamination in lung, heart-lung, heart and liver transplantation. Infection 2008; 36 (3) 207-212
- 68 Len O, Gavaldà J, Blanes M , et al; Spanish Research Network for the Study of Infection in Transplantation. Donor infection and transmission to the recipient of a solid allograft. Am J Transplant 2008; 8 (11) 2420-2425
- 69 Palacios G, Druce J, Du L , et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 2008; 358 (10) 991-998
- 70 Iwamoto M, Jernigan DB, Guasch A , et al; West Nile Virus in Transplant Recipients Investigation Team. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348 (22) 2196-2203
- 71 Srinivasan A, Burton EC, Kuehnert MJ , et al; Rabies in Transplant Recipients Investigation Team. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005; 352 (11) 1103-1111
- 72 Halpern SD, Shaked A, Hasz RD, Caplan AL. Informing candidates for solid-organ transplantation about donor risk factors. N Engl J Med 2008; 358 (26) 2832-2837
- 73 Fong TL, Cho YW, Hou L, Hutchinson IV, Barbers RG, Herrington CS. Outcomes after lung transplantation and practices of lung transplant programs in the United States regarding hepatitis C seropositive recipients. Transplantation 2011; 91 (11) 1293-1296
- 74 Davern TJ, Chalasani N, Fontana RJ , et al; Drug-Induced Liver Injury Network (DILIN). Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011; 141 (5) 1665-1672 , e1–e9
- 75 Bonser RS, Taylor R, Collett D, Thomas HL, Dark JH, Neuberger J. Cardiothoracic Advisory Group to NHS Blood and Transplant and the Association of Lung Transplant Physicians (UK). Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry. Lancet 2012; 380 (9843) 747-755
- 76 Macrae F. Cystic fibrosis sufferer given smoker's lungs in transplant dies of cancer. Available at: www.dailymail.co.uk/health/article-2249189
- 77 Oto T, Excell L, Griffiths AP, Levvey BJ, Snell GI. The implications of pulmonary embolism in a multiorgan donor for subsequent pulmonary, renal, and cardiac transplantation. J Heart Lung Transplant 2008; 27 (1) 78-85
- 78 Ferraro P, Martin J, Dery J , et al. Late retrograde perfusion of donor lungs does not decrease the severity of primary graft dysfunction. Ann Thorac Surg 2008; 86 (4) 1123-1129
- 79 Sapru A, Zaroff JG, Pawlikowska L , et al; DOGMATIC Study Investigators. The 4G/4G genotype of the PAI-1 (serpine-1) 4G/5G polymorphism is associated with decreased lung allograft utilization. Am J Transplant 2012; 12 (7) 1848-1854
- 80 Kaneda H, Waddell TK, de Perrot M , et al. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant 2006; 6 (3) 544-551
- 81 Anraku M, Cameron MJ, Waddell TK , et al. Impact of human donor lung gene expression profiles on survival after lung transplantation: a case-control study. Am J Transplant 2008; 8 (10) 2140-2148
- 82 Ray M, Dharmarajan S, Freudenberg J, Zhang W, Patterson GA. Expression profiling of human donor lungs to understand primary graft dysfunction after lung transplantation. Am J Transplant 2007; 7 (10) 2396-2405
- 83 Oto T, Excell L, Griffiths AP , et al. Association between primary graft dysfunction among lung, kidney and heart recipients from the same multiorgan donor. Am J Transplant 2008; 8 (10) 2132-2139
- 84 Cooper DK. Hormonal resuscitation therapy in the management of the brain-dead potential organ donor. Int J Surg 2008; 6 (1) 3-4
- 85 Shah VR. Aggressive management of multiorgan donor. Transplant Proc 2008; 40 (4) 1087-1090
- 86 Venkateswaran RV, Patchell VB, Wilson IC , et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg 2008; 85 (1) 278-286 , discussion 286
- 87 Rosendale JD, Kauffman HM, McBride MA , et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 2003; 75 (4) 482-487
- 88 Steen S, Sjöberg T, Liao Q, Bozovic G, Wohlfart B. Pharmacological normalization of circulation after acute brain death. Acta Anaesthesiol Scand 2012; 56 (8) 1006-1012
- 89 Rostron AJ, Avlonitis VS, Cork DM, Grenade DS, Kirby JA, Dark JH. Hemodynamic resuscitation with arginine vasopressin reduces lung injury after brain death in the transplant donor. Transplantation 2008; 85 (4) 597-606
- 90 Minambres E, Ballesteros MA, Rodrigo E , et al. Aggressive lung donor management increases graft procurement without increasing renal graft loss after transplantation. Clin Transplant 2013; 27 (1) 52-59
- 91 Christmas AB, Bogart TA, Etson KE , et al. The reward is worth the wait: a prospective analysis of 100 consecutive organ donors. Am Surg 2012; 78 (3) 296-299
- 92 Mascia L, Pasero D, Slutsky AS , et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA 2010; 304 (23) 2620-2627
- 93 Marasco SF, Bailey M, McGlade D , et al. Effect of donor preservation solution and survival in lung transplantation. J Heart Lung Transplant 2011; 30 (4) 414-419
- 94 Cypel M, Yeung JC, Hirayama S , et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008; 27 (12) 1319-1325
- 95 Aigner C, Slama A, Hötzenecker K , et al. Clinical ex vivo lung perfusion—pushing the limits. Am J Transplant 2012; 12 (7) 1839-1847
- 96 Zych B, Popov AF, Stavri G , et al. Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning. J Heart Lung Transplant 2012; 31 (3) 274-281
- 97 Cypel M, Yeung JC, Machuca T , et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg 2012; 144 (5) 1200-1206
- 98 Dong BM, Abano JB, Egan TM. Nitric oxide ventilation of rat lungs from non-heart-beating donors improves posttransplant function. Am J Transplant 2009; 9 (12) 2707-2715
- 99 Inci I, Ampollini L, Arni S , et al. Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. J Heart Lung Transplant 2008; 27 (11) 1229-1236
- 100 Inci I, Zhai W, Arni S , et al. Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. J Heart Lung Transplant 2007; 26 (10) 1054-1060
- 101 Hirayama S, Cypel M, Sato M , et al. Activated protein C in ischemia-reperfusion injury after experimental lung transplantation. J Heart Lung Transplant 2009; 28 (11) 1180-1184
- 102 Ishiyama T, Dharmarajan S, Hayama M, Moriya H, Grapperhaus K, Patterson GA. Inhibition of nuclear factor kappaB by IkappaB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J Thorac Cardiovasc Surg 2005; 130 (1) 194-201
- 103 Yeung JC, Wagnetz D, Cypel M , et al. Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation in the pig. Mol Ther 2012; 20 (6) 1204-1211
- 104 Cypel M, Rubacha M, Yeung J , et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 2009; 9 (10) 2262-2269